Sign up for free psoriasis treatment tips by email.

EMAIL ADDRESS:


Find us on Facebook




Latest News

SEE ALLOur Sponsors




Archive for the ‘Biologics’ Category

« Previous Page

The Top Psoriasis Stories of 2011

January 25th 2012 | Biologics, Patient Stories, Psoriasis Cure Now, Psoriasis Research, psoriatic arthritis, Public policy issues | 4 Comments
Be Sociable, Share!

Before 2011 becomes a distant memory, Psoriasis Cure Now felt it would be useful to highlight what we believe were the top psoriasis and psoriatic arthritis stories of 2011. The year included bad news about a promising treatment from Abbot buy cialis online uk t, as well as a psoriasis sub-plot to one of the
READ THE FULL POST

Phil Mickelson ‘On Course with Phil’ campaign launches for psoriasis, arthritis

March 2nd 2011 | Biologics, Health care system, psoriatic arthritis, Public policy issues | 1 Comment
Be Sociable, Share!

We’re happy to see the Phil Mickelson psoriasis, psoriatic arthritis, and RA campaign launch. Go Phil! We hope he is winning again soon. The campaign is called On Course with Phil, and you can see the site here:

Clinical trials of FDA-approved psoriasis treatments can be a good option

January 19th 2011 | Biologics, Psoriasis Research, Treatment | 0 Comments
Be Sociable, Share!

Even treatments that are already approved by the U.S. Food and Drug Administration (FDA) are frequently tested further in clinical trials under close medical supervision. Such trials typically offer free meds and thorough medical screening – a gre WORK FROM NO HOME at deal for patients. Check out our full report on psoriasis research studies
READ THE FULL POST

Abbott withdraws application to market briakinumab for psoriasis

January 15th 2011 | Biologics, Psoriasis Research, Side-effects of treatment | 13 Comments
Be Sociable, Share!

Abbott today announced in a securities filing that it has withdrawn its application with the U.S. Food and Drug Administration (FDA) and European regulators to market its much-anticipated, experimental

Briakinumab (ABT-874) Phase Three psoriasis trial results bring joy, concern

October 11th 2010 | Biologics, Psoriasis Research, Side-effects of treatment, Treatment | 11 Comments
Be Sociable, Share!

[UPDATE 1/14/2011: Abbott today announced that it has withdrawn its application with the U.S. FDA to market briakinumab (ABT-874, Ozespa). Our full analysis of Abbott's pulling its briakinumab application is here. Our original, unedited post concerning the Phase Three trials is below.] You know that buzz about Centocor Ortho Biotech’s biologic Stelara (ustekinumab), the first
READ THE FULL POST

New Stelara data show strong results for psoriasis patients maintained for nearly 3 years

October 7th 2010 | Biologics, Psoriasis Research, Treatment | 0 Comments
Be Sociable, Share!

New data on Stelara (ustekinumab) has been presented at a European scientific meeting, and it shows Stelara performing well for most patients in the clinical trial, even after 2 cheap viagra years and 10 months of use. The company’s press release is here. Some background on the study the data came from: Patients who weighed
READ THE FULL POST

Powerful UK health care agency seeks to block psoriatic arthritis patient access to Simponi in Britain

October 6th 2010 | Biologics, Health care system, psoriatic arthritis, Public policy issues | 0 Comments
Be Sociable, Share!

In what may be a look at the future of the U.S. health care system, the National Institute for Health and Clinical Excellence (NICE) in Britain has recommended denying psoriatic arthritis patients reimbursement for the biologic Simponi (golimumab) in the country’s government-run health care system. NICE has generated great controversy in the United States, with
READ THE FULL POST

NY moves to limit insurance cost-shifting to patients for high-priced specialty drugs

October 5th 2010 | Biologics, Health care system, Insurance, Public policy issues | 0 Comments
Be Sociable, Share!

New York Governor David Patterson recently signed many new measures into law, including one that could benefit psoriasis and psoriatic arthritis patients being treated with biologics: Among the bills signed by Governor Paterson is S.5000-B/A.8278-B, which will codify in law the currently regulatory authority of the State Insurance Department to disapprove requests from insurance carriers
READ THE FULL POST

Stelara update: can keep working for 3 years, safely

August 15th 2010 | Biologics, Psoriasis Research, Treatment | 2 Comments
Be Sociable, Share!

Even before it received U.S. Food and Drug Administration (FDA) approval in September 2009, Stelara (ustekinumab) had considerable buzz in the psoriasis community. Imagine a treatment that (after two initial doses) you take just four times a year! But the early buzz was based on 12 week, and later 40 week, studies. That left two
READ THE FULL POST

Golf star Phil Mickelson has psoriatic arthritis

August 11th 2010 | Biologics, Patient Stories, psoriatic arthritis, Treatment | 0 Comments
Be Sociable, Share!

The golf world was stunned yesterday by the news that superstar Phil Mickelson has been battling psoriatic arthritis this summer. He announced in a press conference that a severe flare of psoriatic arthritis had left him in a state where he “couldn’t move.” Read our full report on Phil Mickelson’s psoriatic arthritis.

« Previous Page
© 2005-2014 Psoriasis Cure Now WEB DESIGN BY SKYHOOK MARKETING